Lakewood-Amedex Biotherapeutics

CompanyUnited States

Lakewood-Amedex Biotherapeutics develops one asset, preclinical (Nu-8 in pulmonary infection). Mostly small molecule; based in the United States.

1
Asset
Furthest stage
Preclinical
0
Trials
0
Signals

Pipeline

1
  • Nu-8

    Bisphosphocin antimicrobial compound inhibiting bacterial growth

    Preclinical, Small molecule, pulmonary infection, urinary tract infection

Full company profiles: pipeline, trials, funding and people.

See Pro

Intelligence